t.cardoso
Submits third-party assay reports on material purchased directly. Based in Bochum.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.98%
n=9
Suppliers covered
9
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043319 | BPC-157 | CPC | CPC-2602-W1610 | Medutest | 2026-Q3 | 98.82 | 2.88 | 103.5 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-042743 | BPC-157 | GGPeps | GGPE-2602-E1411 | Janoshik | 2026-Q2 | 98.98 | 4.40 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020525 | Semaglutide | SSA | SSA-2502-U6907 | Kestrel | 2025-Q3 | 98.10 | 5.12 | 98.8 | Buyer-sourced | 0 | PASS |
| AX-2025-020743 | Triptorelin | SGN | SGN-2504-A9334 | Janoshik | 2025-Q2 | 99.43 | 4.95 | 105.6 | Supplier-supplied | 0 | PASS |
| AX-2024-004794 | SS-31 (Elamipretide) | Homopeptide | HOMO-2410-K5866 | Janoshik | 2024-Q4 | 99.66 | 3.94 | 93.6 | Buyer-sourced | 0 | PASS |
| AX-2024-004273 | AOD-9604 | QSC | QSC-2406-G5496 | Janoshik | 2024-Q3 | 99.86 | 5.86 | 101.8 | Buyer-sourced | 0 | PASS |
| AX-2024-004405 | PT-141 (Bremelanotide) | ASY | ASY-{CAT}-2723 | Janoshik | 2024-Q3 | 99.62 | 4.11 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004859 | Tirzepatide | ERP | ERP-2401-D8257 | Medutest | 2024-Q2 | 98.26 | 4.36 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004654 | Retatrutide | TFC | TFC-2309-H2397 | Janoshik | 2024-Q1 | 98.48 | 4.64 | 100.7 | Buyer-sourced | 0 | PASS |